Work with thought leaders and academic experts in general immunology microbiology

Companies can greatly benefit from working with General Immunology and Microbiology experts. These experts possess in-depth knowledge and understanding of the immune system and microbial organisms, allowing them to contribute to various areas such as drug development, vaccine research, diagnostics, and disease prevention. By collaborating with these experts, companies can enhance their research capabilities, develop innovative solutions, and stay ahead in the field. They can also gain access to cutting-edge technologies, specialized equipment, and valuable industry connections. Furthermore, General Immunology and Microbiology experts can provide valuable insights and guidance in navigating regulatory requirements and ensuring compliance. Overall, partnering with these experts can lead to accelerated scientific advancements, improved product development, and increased competitiveness in the market.

Experts on NotedSource with backgrounds in general immunology microbiology include Edoardo Airoldi, Jeffrey Townsend, Luke Connelly, Fadhel Kaboub, Peter Reich, Mohsen Omrani, Amir Manbachi, Kayvan Najarian, Dr. Susanne Ressl, Gianfranco Santovito, Patrick Reeson, Matheus Ferraz, John Joe, and Shruti Muralidhar.

Luke Connelly

Professor of Health Economics, The University of Queensland, CBEH
Most Relevant Research Interests
Other Research Interests (53)
Health economics
Public Health, Environmental and Occupational Health
Safety, Risk, Reliability and Quality
Human Factors and Ergonomics
And 48 more
Luke Connelly is Professor of Health Economics at the Centre for the Business and Economics of Health. He also holds a Professorial appointment (part-time) at The University of Bologna, to which he was appointed in 2017 via the Italian “Direct Call” ([link]( process. In 2019 he was appointed as Honorary Professor at The University of Sydney. His main interests are in health economics and insurance economics and the effects of institutions (including legal constructs) on incentives and behaviour. He has also worked in other fields of applied microeconomics, including education economics and transport economics. His publications include papers in *Review of Income and Wealth*, *Health Economics*, *Journal of Health Economics*, *Journal of Risk and Insurance*, *Geneva Papers on Risk and Insurance*, *Accident Analysis and Prevention*, *Journal of Law and Medicine*, *Journal of Clinical Epidemiology*, *European Journal of Health Economics*, *International Journal of Health Economics and Finance*, *Social Science and Medicine*, *Economic Papers*, *Economic Analysis and Policy*, *Journal of Transport Economics and Policy*, *Labour Economics*, *Economics and Human Biology* as well as in a range of clinical journals, including *Lancet*. Luke has served on a number of public committees including the Medical Services Advisory Committee (MSAC), which advises the Australian Minister for Health on the safety, efficacy, effectiveness, and cost-effectiveness of new and extant listings on Australia's Medicare Benefits Schedule. He has extensive service on other public committees and taskforces as well as extensive teaching and consulting engagements with industry. Over his career he has been a chief investigator on research grants and contracts totalling more than $67m. He is a member of the Editorial Boards of European Journal of Health Economics and the International Journal on Environmental Research and Public Health. He is a member of the International Health Economics Association's Arrow Awards Committee, which awards an annual prize in honour of Nobel Laureate Kenneth Arrow for the best paper in the field. He is currently Guest Editor (with Christophe Courbage) on a Special Issue of the Geneva Papers on Risk and Insurance on Insurance and Emerging Health Risks. His current research interests include health service innovations to improve the health of people with chronic kidney disease(CKD). Ongoing interests include the economics of disability and insurance, compensable injury compensation schemes, and the determinants of health. Luke enjoys and has considerable experience teaching economics and health economics at both the graduate and undergraduate levels. In 2014 he was awarded the School of Economics Distinguished Teaching Award for his teaching on UQ's Master of Health Economics Program. In July 2016 and July 2019 he also taught summer schools in Health Economics and the Economics of Insurance at The University of Lucerne, Switzerland. Over the past 10 years he has been a chief investigator on grants totalling more than $70m.

Example general immunology microbiology projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on general immunology microbiology?

Drug Development

A pharmaceutical company can collaborate with a General Immunology and Microbiology expert to develop new drugs targeting specific immune responses or microbial infections. The expert's knowledge of immunological pathways and microbial mechanisms can help identify potential drug targets and design effective therapeutic strategies.

Vaccine Research

A biotechnology company can partner with a General Immunology and Microbiology expert to advance vaccine research. The expert can contribute to the identification of vaccine candidates, formulation development, and evaluation of immune responses. This collaboration can accelerate the development of safe and effective vaccines against infectious diseases.


A diagnostic company can collaborate with a General Immunology and Microbiology expert to develop innovative diagnostic tools and assays. The expert's understanding of immune responses and microbial interactions can aid in the design of sensitive and specific diagnostic tests for various diseases, including autoimmune disorders and infectious diseases.

Disease Prevention

A healthcare company can work with a General Immunology and Microbiology expert to develop strategies for disease prevention. The expert can provide insights into the immune system's role in disease susceptibility and guide the development of preventive measures, such as vaccines, probiotics, and immune-boosting interventions.

Microbiome Research

A research institute can collaborate with a General Immunology and Microbiology expert to study the human microbiome. The expert's expertise in microbial ecology and host-microbe interactions can contribute to understanding the role of the microbiome in health and disease. This collaboration can lead to the development of targeted therapies and interventions for microbiome-related disorders.